PMCPA Case Library

1,752 PMCPA Rulings.
Every One Analysed.

The only structured, searchable PMCPA case library in the UK. Expert video walkthroughs, podcast episodes, and MCQ assessments on every ruling — so you understand why companies breach the Code, not just that they did.

▶ Video analysis per case
🎧 Podcast per case
✍ MCQ + CPD certificate
🔒 From £299/year
1752+
Case Studies
5 min
Per Video
5 pts
Per Case Passed
8
Themes
📚
Subscribe for full case library access
Read free summaries below, or subscribe to unlock expert video walkthroughs, podcast audio and CPD certificates.
Free — Browsing
✓ Browse all 1752+ case titles
✓ Filter by theme & therapy area
✓ See case reference, company & outcome
Search by company or clause
Video walkthroughs
Podcast episodes
MCQ assessments & CPD certificates
Subscribed — Full Access
✓ Search by company, clause & case ref
✓ Expert video walkthrough per case
✓ Podcast episode per case
✓ MCQ quiz — 5 CPD points per pass
✓ Personalised CPD completion certificate
✓ New cases added monthly
Subscribe from £299/year →
Search by company, clause, case reference... 🔒
Therapy Area: All areas Other (360) Oncology (218) Cardiovascular (189) Respiratory (178) CNS & Neurology (169) Infectious Diseases (115) Diabetes (114) Rare Diseases (104) Immunology & Rheumatology (84) Dermatology (67) Obesity & Weight Management (63) Musculoskeletal & Bone (60) Ophthalmology (31)
Showing 30 results · Data & Publications · Rare Diseases  · Clear
🔒 Subscribers only
AUTH/3365/7/20
Data & Publications Upheld 🏥 Rare Diseases ▶ Video 🎙 Podcast
Norgine breached ABPI Code over Feraccru email claiming major cost and nursing-time savings vs IV ir
A UK health professional complained about a promotional email for Feraccru (ferric maltol) sent via Guidelines in Practice to prescribers, commissioners and NHS decision makers.The email headline a…
Clauses: 9.1,9.2
🔒 Subscribers only
AUTH/3159/2/19
Data & Publications Not Upheld 🏥 Rare Diseases ▶ Video 🎙 Podcast
Vifor
Pharmacosmos complained that Vifor medical personnel proactively contacted UK health professionals to discuss safety data from Ehlken et al (2018) about severe hypersensitivity reactions, comparing…
Clauses: NONE
🔒 Subscribers only
AUTH/3259/10/19
Data & Publications Not Upheld 🏥 Rare Diseases ▶ Video 🎙 Podcast
Otsuka Europe
An employee complained about Otsuka Europe regarding EU risk minimisation plan (RMP) / additional risk minimisation measures (aRMM) materials for Jinarc (tolvaptan), alleging patient safety risk an…
Clauses: NONE
🔒 Subscribers only
AUTH/3096/9/18
Data & Publications Not Upheld 🏥 Rare Diseases ▶ Video 🎙 Podcast
AUTH/3096/9/18 Director v Shire
Clauses: NONE
🔒 Subscribers only
AUTH/3100/9/18
Data & Publications Not Upheld 🏥 Rare Diseases ▶ Video 🎙 Podcast
Pierre Fabre
A complaint was made by the Director against Pierre Fabre.The subject matter related to clinical trial disclosure.The PMCPA determined the matter was outwith the scope of the ABPI Code (Applicable …
Clauses: NONE
🔒 Subscribers only
AUTH/3095/9/18
Data & Publications Not Upheld 🏥 Rare Diseases ▶ Video 🎙 Podcast
Actelion
A complaint was made by the Director against Actelion.The subject matter related to clinical trial disclosure.The PMCPA determined the matter was outwith the scope of the ABPI Code of Practice (App…
Clauses: NONE
🔒 Subscribers only
AUTH/3092/9/18
Data & Publications Not Upheld 🏥 Rare Diseases ▶ Video 🎙 Podcast
Celgene
A complaint was brought by the Director against Celgene.The subject matter related to clinical trial disclosure.The PMCPA determined the matter was outwith the scope of the ABPI Code (2016).
Clauses: NONE
🔒 Subscribers only
AUTH/3018/2/18
Data & Publications Upheld 🏥 Rare Diseases ▶ Video 🎙 Podcast
Tesaro
Tesaro UK identified (via an internal email in Feb 2018) that seven hard-copy promotional items for Zejula (niraparib) might have been distributed to the field team before certification of their fi…
Clauses: 9.1
🔒 Subscribers only
AUTH/2984/10/17
Data & Publications Not Upheld 🏥 Rare Diseases ▶ Video 🎙 Podcast
Astellas UK
A hospital doctor alleged Astellas UK inappropriately awarded research funding (~£250,000) in 2009 in association with use of Advagraf (tacrolimus) in a renal transplant protocol (Advagraf de novo…
Clauses: NONE
🔒 Subscribers only
AUTH/3007/12/17
Data & Publications Not Upheld 🏥 Rare Diseases ▶ Video 🎙 Podcast
Vifor Fresenius
The PMCPA Director reviewed a matter relating to clinical trial disclosure for Velphoro involving Vifor Fresenius.The review was assessed under the ABPI Code of Practice (Applicable Code year: 2016…
Clauses: NONE
🔒 Subscribers only
AUTH/3003/12/17
Data & Publications Not Upheld 🏥 Rare Diseases ▶ Video 🎙 Podcast
Clinuvel UK
A complaint was brought by the PMCPA Director against Clinuvel UK.The subject matter related to clinical trial disclosure for Scenesse.Complaint received: 20 December 2017.
Clauses: NONE
🔒 Subscribers only
AUTH/3002/12/17
Data & Publications Not Upheld 🏥 Rare Diseases ▶ Video 🎙 Podcast
Octapharma
The PMCPA Director raised a case against Octapharma concerning clinical trial disclosure relating to Nuwiq.The case was considered under the ABPI Code of Practice (Applicable Code year: 2016).
Clauses: NONE
🔒 Subscribers only
AUTH/2979/9/17
Data & Publications Upheld 🏥 Rare Diseases ▶ Video 🎙 Podcast
PharmaMar
A case was brought by an anonymous, non-contactable complainant against PharmaMar.The case reference is AUTH/2979/9/17.No further factual background was provided in the supplied case text.
🔒 Subscribers only
AUTH/2891/11/16
Data & Publications Not Upheld 🏥 Rare Diseases ▶ Video 🎙 Podcast
Astellas
An ex-employee made a complaint about Astellas.The case topic is listed as “Certification and review of materials”.The PMCPA considered the matter under the ABPI Code process.
Clauses: NONE
🔒 Subscribers only
AUTH/2894/11/16
Data & Publications Not Upheld 🏥 Rare Diseases ▶ Video 🎙 Podcast
Mitsubishi Tanabe
A complaint was brought by the Director against Mitsubishi Tanabe.The subject matter related to clinical trial disclosure for BindRen.The case was completed on the same date it was received.
Clauses: NONE
🔒 Subscribers only
AUTH/2844/5/16
Data & Publications Not Upheld 🏥 Rare Diseases ▶ Video 🎙 Podcast
Amdipharm Mercury
Amdipharm Mercury Company (AMCo) voluntarily admitted that a representative sent an unapproved promotional email about Lutrate (leuprorelin) to a prescribing advisor.The email was discovered during…
Clauses: NONE
🔒 Subscribers only
AUTH/2805/12/15
Data & Publications Not Upheld 🏥 Rare Diseases ▶ Video 🎙 Podcast
Guerbet
Bayer complained that Guerbet (and others) offered radiological contrast injection equipment on long-term loan or as a gift to customers who agreed to purchase the company’s contrast agent.Bayer …
Clauses: NONE
🔒 Subscribers only
AUTH/2769/5/15
Data & Publications Not Upheld 🏥 Rare Diseases ▶ Video 🎙 Podcast
Takeda
PMCPA Director considered a matter relating to clinical trial disclosure for Rienso involving Takeda.The case was assessed under the ABPI Code applicable in 2015.
Clauses: NONE
🔒 Subscribers only
AUTH/2688/1/14
Data & Publications Not Upheld 🏥 Rare Diseases ▶ Video 🎙 Podcast
Auxilium
A member of the public made a complaint concerning clinical trial disclosure relating to Xiapex.The PMCPA considered whether the matter fell within the scope of the ABPI Code of Practice.
Clauses: NONE
🔒 Subscribers only
AUTH/2665/11/13
Data & Publications Not Upheld 🏥 Rare Diseases ▶ Video 🎙 Podcast
Genzyme (Sanofi)
An anonymous, contactable member of the public complained about clinical trial disclosure information referenced via an ABPI-funded study published in Current Medical Research & Opinion (11 Nov…
Clauses: NONE
🔒 Subscribers only
AUTH/2660/11/13
Data & Publications Not Upheld 🏥 Rare Diseases ▶ Video 🎙 Podcast
HRA Pharma
A member of the public made a complaint about clinical trial disclosure relating to ellaOne.The complaint was considered under the ABPI Code of Practice (Applicable Code year: 2012).The PMCPA concl…
Clauses: NONE
🔒 Subscribers only
AUTH/2514/6/12
Data & Publications Not Upheld 🏥 Rare Diseases ▶ Video 🎙 Podcast
Baxter
Baxter reserved marketing space in Haemophilia for a FEIBA advertisement.The publisher requested draft artwork for typesetting; Baxter’s agency supplied draft copy, stating it was not to be print…
Clauses: NONE
🔒 Subscribers only
AUTH/2499/4/12
Data & Publications Upheld 🏥 Rare Diseases ▶ Video 🎙 Podcast
Sanofi breached ABPI Code after sales rep told clinician an IFR for Mozobil “will” be approved
A pharmacist adviser for a specialised commissioning group complained about an email from a Sanofi haematology sales representative to a hospital clinician about local funding for Mozobil (plerixaf…
Clauses: 9.1,15.2
🔒 Subscribers only
AUTH/2498/4/12
Data & Publications Upheld 🏥 Rare Diseases ▶ Video 🎙 Podcast
Merck Serono
Sandoz complained that Merck Serono provided a rucksack with a removable cool bag as a Saizen (somatropin) patient support item.Sandoz alleged the rucksack was not related to treatment of growth ho…
Clauses: 18.2
1 2 Next → Page 1 of 2 — 30 cases
Unlock the Full Case Library
Annual subscription — instant access, cancel anytime.
🏆
The only PMCPA case library of its kind
No other provider publishes a structured, searchable library of PMCPA rulings with video and podcast. A single half-day compliance workshop from a specialist provider typically costs £499+ — for one session. Individual access here is £299 for a full year of 2,000+ cases.
PMCPA Case Library — Team (100 seats)
Custom pricing
tailored to your team size
Bulk pricing available — contact us for a quote
Enquire for bulk pricing →
Individual
For a single learner
£299
per year
Less than a single half-day workshop
  • 1 user seat
  • All 1752+ case studies
  • Video + podcast per case
  • MCQ quiz per case
  • 5 points per case passed
  • New cases added monthly
Create account or sign in to buy
Team 25+
25+ team members
Custom pricing
tailored to your team size
Bulk pricing available — contact us for a quote
  • 25 user seats
  • All case studies included
  • Video, podcast & MCQ per case
  • Team progress dashboard
  • Bulk seat management
  • Priority support
Enquire for bulk pricing →

Questions? Email [email protected]  ·  14-day money-back guarantee  ·  Annual subscription, auto-renews